pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
KTX-2001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
K36 Therapeutics Inc
0
catalysts
Phase 1
KY-0118
Colorectal Cancer
Shanghai Keyi Pharmaceutical Technology Co Ltd
0
catalysts
Preclinical
KY-0601
Colorectal Cancer
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Preclinical
KY-0901
← prev
page 25 of 62
next →
131
Pain
89
Neurology
1
Bile Duct Cancer (Cholangiocarcinoma)
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Preclinical
LADR-7
Head And Neck Squamous Cell Carcinoma (HNSC)
LadRx Corp
0
catalysts
Phase 2
LAT-010
Breast Cancer
Latticon Antibody Therapeutics Inc
0
catalysts
Phase 2
LB-100
Myelodysplastic Syndrome (Preleukemia)
Serine/threonine-protein phosphatase 5
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
$LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
0
catalysts
Phase 1
LB-1908
Adenocarcinoma Of The Gastroesophageal Junction
$LEGN
Legend Biotech Corp
0
catalysts
Phase 2
LB-2102
Neuroendocrine Carcinoma
$NVS
NOVARTIS AG
0
catalysts
Preclinical
LBL-043
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBL-049
Cancer Anorexia-Cachexia Syndrome
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBL-061
Head And Neck Squamous Cell Carcinoma (HNSC)
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LCB-39
Breast Cancer
LigaChem Biosciences Inc
0
catalysts
Phase 2
LCB-71
Diffuse Large B-Cell Lymphoma
CStone Pharmaceuticals Co Ltd
0
catalysts
Phase 2
LG-631
Glioblastoma Multiforme (GBM)
Lentigen Technology Inc
0
catalysts
Phase 2
LIOCYXM-004
Hepatocellular Carcinoma
Lion TCR Pte Ltd
0
catalysts
Phase 1
LIS-22
Peripheral T-Cell Lymphomas (PTCL)
Xenothera SAS
0
catalysts
Preclinical
LLS-30
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Kibio Inc
0
catalysts
Phase 2
LM-24C5
Solid Tumor
LaNova Medicines Ltd
0
catalysts
Phase 2
LMP-744
Recurrent Glioblastoma Multiforme (GBM)
Gibson Oncology LLC
0
catalysts
Phase 1
LMY-920
Mantle Cell Lymphoma
Luminary Therapeutics Inc
0
catalysts
Phase 1
LNCB-74
Bile Duct Cancer (Cholangiocarcinoma)
$NXTC
NextCure, Inc.
0
catalysts
Phase 3
LNS-8801
Metastatic Melanoma
Linnaeus Therapeutics Inc
0
catalysts
Phase 2
LNTH-2403
Osteosarcoma
$LNTH
Lantheus Holdings, Inc.
0
catalysts
Phase 2
LOAd-703
Pancreatic Ductal Adenocarcinoma
Lokon Pharma AB
0
catalysts
Phase 1
LP-118
Anaplastic Large Cell Lymphoma (ALCL)
Newave Pharmaceutical Co Ltd
0
catalysts
Preclinical
LP-182
Myelofibrosis
Lympharma LLC
0
catalysts
Phase 2
LP-184
Central Nervous System (CNS) Cancer
Starlight Therapeutics Inc
0
catalysts
Phase 1
LP-284
B-Cell Non-Hodgkin Lymphoma
$LTRN
Lantern Pharma Inc.
0
catalysts
Phase 1
LR-19155
Head And Neck Squamous Cell Carcinoma (HNSC)
LG Chem Ltd
0
catalysts
